Literature DB >> 26699739

Dexmedetomidine-fentanyl Compared With Midazolam-fentanyl for Conscious Sedation in Patients Undergoing Lumbar Disc Surgery.

Ke Peng1, Hua-Yue Liu1, Si-Lan Liu1, Fu-Hai Ji2.   

Abstract

PURPOSE: Patients undergoing awake lumbar disc surgery need adequate sedation and analgesia. This study investigated whether use of a dexmedetomidine-fentanyl (DF) regimen could be superior to midazolam-fentanyl (MF) for these patients.
METHODS: Sixty patients scheduled for elective lumbar laminotomy and discectomy were randomly assigned to receive either DF or MF for conscious sedation. Patient-controlled intravenous analgesia with fentanyl was used for postoperative pain management. Hemodynamic and respiratory changes, sedation scores, pain scores, fentanyl consumption, patient satisfaction, postoperative hospital stay, and adverse events were assessed.
FINDINGS: The patient and surgical characteristics, sedation levels, and pain scores were similar in the 2 groups. Compared with the MF group, heart rate was lower in the DF group at six time points from skin incision to 15 minutes in the postanesthesia care unit (PACU), they are skin incision, 15 min after the beginning of surgery, 30 min after the beginning of surgery, skin closure, entering PACU, and 15 min in PACU (P = 0.016, 0.002, 0.000, 0.000, 0.000, and 0.001, respectively), whereas pulse oxygen saturation was higher at 3 time points from 15 minutes after the beginning of surgery to skin closure (P = 0.022, 0.026, and 0.025, respectively). The intraoperative, postoperative, and total consumption of fentanyl were lower in the DF group (total: mean difference = -69.3 µg; 95% CI, = -114.3 to -24.4; P = 0.003). No significant differences were found for adverse events, postoperative hospital stay, or satisfaction between the 2 groups. IMPLICATIONS: Although awake lumbar disc surgery can be performed successfully under sedation with either MF or DF combination, the latter may be a better alternative because of less consumption of opioid analgesics. ChiCTR.org identifier: ChiCTR-TRC-13003645.
Copyright © 2016 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Keywords:  analgesia; dexmedetomidine; discectomy; laminotomy; midazolam; sedation

Mesh:

Substances:

Year:  2015        PMID: 26699739     DOI: 10.1016/j.clinthera.2015.11.016

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  5 in total

1.  Dexmedetomidine as a sedative and analgesic adjuvant in spine surgery: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Georgia G Tsaousi; Chryssa Pourzitaki; Simone Aloisio; Federico Bilotta
Journal:  Eur J Clin Pharmacol       Date:  2018-07-14       Impact factor: 2.953

2.  Dexmedetomidine Prevents Lipopolysaccharide-Induced MicroRNA Expression in the Adult Rat Brain.

Authors:  Nadine Paeschke; Clarissa von Haefen; Stefanie Endesfelder; Marco Sifringer; Claudia D Spies
Journal:  Int J Mol Sci       Date:  2017-08-23       Impact factor: 5.923

3.  Effects of propofol anesthesia versus sevoflurane anesthesia on postoperative pain after radical gastrectomy: a randomized controlled trial.

Authors:  Fu-Hai Ji; Dan Wang; Juan Zhang; Hua-Yue Liu; Ke Peng
Journal:  J Pain Res       Date:  2018-06-25       Impact factor: 3.133

4.  Neurosurgical Management of Interspinous Device Complications: A Case Series.

Authors:  T J Florence; Irene Say; Kunal S Patel; Ansley Unterberger; Azim Laiwalla; Andrew C Vivas; Daniel C Lu
Journal:  Front Surg       Date:  2022-03-16

5.  Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury.

Authors:  Hengchang Li; Chengxiang Lu; Wenfei Yao; Lixin Xu; Jun Zhou; Bin Zheng
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.